Literature DB >> 14523271

Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans.

Jeffrey R Currier1, William E Dowling, K Monique Wasunna, Uzma Alam, Carl J Mason, Merlin L Robb, Jean K Carr, Francine E McCutchan, Deborah L Birx, Josephine H Cox.   

Abstract

OBJECTIVES: To quantitate rapidly the frequency of HIV-1 subtype-specific and broadly HIV-1 cross-subtype-reactive CD8 T cells in the peripheral blood of HIV-1-infected individuals from a geographical region of multiple subtype endemicity.
METHODS: Autologous B-lymphoblastoid cell lines infected with recombinant vaccinia-viruses expressing gag, env and nef gene products from HIV-1 subtypes A-H were used as antigen-presenting cells to stimulate CD8 T cells from cryopreserved peripheral blood mononuclear cells. Cross-subtype and subtype-specific CD8 cell responses were assessed by flow cytometry for the upregulation of IFN-gamma gene expression in specifically activated CD8 T cells.
RESULTS: Strikingly high frequencies of circulating CD8 T cells (up to 11.3% of peripheral CD8 T cells) with specificity for HIV-1 were detectable using this methodology. Both subtype-specific and broadly cross-subtype-reactive CD8 T cells were detected as assessed by IFN-gamma production after stimulation. The pattern of cross-subtype reactivity appeared to be random when the results were assessed as a population, but analysis of the full-length sequence of the infecting virus for each individual showed some skewing of the CD8 cell response towards the infecting subtype.
CONCLUSION: High frequencies of HIV-1 cross-subtype-reactive peripheral CD8 T cells can be detected in individuals from a multiple subtype endemic region, providing an incentive for vaccine advancement in such locations. The future assessment of the subtype specificity of cellular immune responses requires full-length sequencing of the infecting virus in conjunction with a comprehensive analysis of phenotypic and functional parameters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523271     DOI: 10.1097/00002030-200310170-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.

Authors:  Wim Jennes; Makhtar Camara; Tandakha Dièye; Souleymane Mboup; Luc Kestens
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

2.  Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants.

Authors:  Gabriela Turk; María Magdalena Gherardi; Natalia Laufer; Mónica Saracco; Renata Luzzi; Josephine H Cox; Pedro Cahn; Horacio Salomon
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

3.  An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort.

Authors:  Harold O Peters; Mark G Mendoza; Rupert E Capina; Ma Luo; Xiaojuan Mao; Michael Gubbins; Nico J D Nagelkerke; Ian Macarthur; Brent B Sheardown; Joshua Kimani; Charles Wachihi; Subo Thavaneswaran; Francis A Plummer
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

4.  Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials.

Authors:  Lycias Zembe; Wendy A Burgers; Heather B Jaspan; Linda-Gail Bekker; Helba Bredell; Gwynneth Stevens; Jill Gilmour; Josephine H Cox; Patricia Fast; Peter Hayes; Eftyhia Vardas; Carolyn Williamson; Clive M Gray
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

5.  CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.

Authors:  Jeffrey R Currier; Unchalee Visawapoka; Sodsai Tovanabutra; Carl J Mason; Deborah L Birx; Francine E McCutchan; Josephine H Cox
Journal:  BMC Immunol       Date:  2006-04-18       Impact factor: 3.615

6.  Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters.

Authors:  Ali Azizi; David E Anderson; Masoud Ghorbani; Katrina Gee; Francisco Diaz-Mitoma
Journal:  BMC Immunol       Date:  2006-10-31       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.